| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF20A MAGI1 MAGI2 CCDC88A CEACAM5 DST LMO7 FMN1 KIF14 MACF1 CORO6 KIF2A TNS4 AGBL5 | 1.42e-04 | 1099 | 82 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule binding | 2.74e-04 | 308 | 82 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 3.72e-04 | 428 | 82 | 8 | GO:0015631 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 1.48e-05 | 78 | 82 | 5 | GO:0001825 | |
| GeneOntologyBiologicalProcess | protein catabolic process | FBXO38 CEACAM5 LATS1 RNF6 UBR5 LAMP3 ANKRD11 HIPK2 KIF14 SNX9 CLOCK CLEC16A RIC1 WAC NEDD4 | 2.94e-05 | 1115 | 82 | 15 | GO:0030163 |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | FBXO38 LATS1 TENT4B RNF6 UBR5 HIPK2 KIF14 CLOCK CLEC16A WAC NEDD4 | 5.58e-05 | 656 | 82 | 11 | GO:0043632 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | MAGI1 MAGI2 BMI1 FBXO38 CEACAM5 LMO7 TJP1 FMN1 KIF14 MACF1 ZFHX3 SEMA6A CASK | 7.05e-05 | 927 | 82 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | FBXO38 LATS1 RNF6 UBR5 LAMP3 ANKRD11 HIPK2 KIF14 CLOCK CLEC16A WAC NEDD4 | 8.41e-05 | 812 | 82 | 12 | GO:0051603 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.10e-04 | 136 | 82 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 2.21e-04 | 640 | 82 | 10 | GO:0006511 | |
| GeneOntologyBiologicalProcess | spermatid nucleus differentiation | 2.51e-04 | 31 | 82 | 3 | GO:0007289 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 2.53e-04 | 651 | 82 | 10 | GO:0019941 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF20A FSIP2 CCDC88A DST CDC42BPA KIF14 MACF1 NCKAP5 CEP131 KIF2A TNP2 TUB SPICE1 | 2.61e-04 | 1058 | 82 | 13 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis involved in protein catabolic process | 2.78e-04 | 79 | 82 | 4 | GO:1903051 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | FSIP2 MAGI2 SEC16B CCDC88A LATS1 UBR5 SEC16A LAMP3 MACF1 CEP131 TUB PYGO1 NEDD4 | 3.51e-04 | 1091 | 82 | 13 | GO:0033365 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CCDC88A LATS1 MYOM1 TJP1 FMN1 PPFIA1 DDR2 KIF14 CORO6 NCKAP5 KIF2A SNX9 | 3.85e-04 | 957 | 82 | 12 | GO:0097435 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.85e-04 | 155 | 82 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 4.26e-04 | 244 | 82 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | inner cell mass cell differentiation | 4.30e-04 | 8 | 82 | 2 | GO:0001826 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum exit site | 4.30e-04 | 8 | 82 | 2 | GO:0070973 | |
| GeneOntologyCellularComponent | cell-cell junction | MAGI1 MAGI2 CEACAM5 DST CDC42BPA LMO7 TJP1 FMN1 PATJ CCDC85A CASK | 1.50e-05 | 591 | 80 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 MAGI2 CEACAM5 DST CDC42BPA LMO7 TJP1 FMN1 PPFIA1 DDR2 TNS4 PATJ CCDC85A CASK | 1.81e-05 | 976 | 80 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | nuclear body | BMI1 SP3 RNF6 PTPRH RAPH1 SIMC1 EPC1 HIPK2 ZFHX3 KIF2A POU2F3 SAP130 WAC | 3.60e-05 | 903 | 80 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | BMI1 SP3 ZFHX4 UBR5 TET1 EPC1 ZBTB22 ANKRD11 ANKRD17 ELF1 ZFHX3 TNP2 CLOCK POU2F3 SAP130 NEDD4 | 1.31e-04 | 1480 | 80 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | adherens junction | 1.63e-04 | 212 | 80 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | centriole | 5.20e-04 | 172 | 80 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | kinesin complex | 8.76e-04 | 49 | 80 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | PML body | 1.36e-03 | 125 | 80 | 4 | GO:0016605 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.61e-03 | 576 | 80 | 8 | GO:0015629 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.61e-03 | 131 | 80 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 2.00e-03 | 139 | 80 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 2.13e-03 | 18 | 80 | 2 | GO:0120212 | |
| Domain | GUANYLATE_KINASE_2 | 2.47e-06 | 23 | 79 | 4 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.47e-06 | 23 | 79 | 4 | PS00856 | |
| Domain | Guanylate_kin | 4.13e-06 | 26 | 79 | 4 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 4.13e-06 | 26 | 79 | 4 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 4.13e-06 | 26 | 79 | 4 | IPR008144 | |
| Domain | GuKc | 4.13e-06 | 26 | 79 | 4 | SM00072 | |
| Domain | Sec16 | 1.77e-05 | 2 | 79 | 2 | IPR024880 | |
| Domain | Sec16 | 1.77e-05 | 2 | 79 | 2 | PF12932 | |
| Domain | Sec16_CCD | 1.77e-05 | 2 | 79 | 2 | IPR024340 | |
| Domain | PDZ | 2.94e-05 | 141 | 79 | 6 | PF00595 | |
| Domain | PDZ | 3.86e-05 | 148 | 79 | 6 | SM00228 | |
| Domain | Guanylate_kinase_CS | 3.92e-05 | 16 | 79 | 3 | IPR020590 | |
| Domain | - | 4.16e-05 | 150 | 79 | 6 | 2.30.42.10 | |
| Domain | PDZ | 4.32e-05 | 151 | 79 | 6 | PS50106 | |
| Domain | PDZ | 4.48e-05 | 152 | 79 | 6 | IPR001478 | |
| Domain | WW | 4.61e-05 | 47 | 79 | 4 | PF00397 | |
| Domain | WW | 5.01e-05 | 48 | 79 | 4 | SM00456 | |
| Domain | Sec16_C | 5.29e-05 | 3 | 79 | 2 | PF12931 | |
| Domain | ACE1_Sec16_Sec31 | 5.29e-05 | 3 | 79 | 2 | IPR024298 | |
| Domain | WW_DOMAIN_2 | 6.37e-05 | 51 | 79 | 4 | PS50020 | |
| Domain | WW_DOMAIN_1 | 6.37e-05 | 51 | 79 | 4 | PS01159 | |
| Domain | WW_dom | 6.88e-05 | 52 | 79 | 4 | IPR001202 | |
| Domain | ZnF_U1 | 2.46e-04 | 29 | 79 | 3 | SM00451 | |
| Domain | Znf_U1 | 2.46e-04 | 29 | 79 | 3 | IPR003604 | |
| Domain | - | 2.62e-04 | 6 | 79 | 2 | 3.90.1290.10 | |
| Domain | GAR | 2.62e-04 | 6 | 79 | 2 | PS51460 | |
| Domain | - | 2.62e-04 | 6 | 79 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 2.62e-04 | 6 | 79 | 2 | IPR003108 | |
| Domain | GAS2 | 2.62e-04 | 6 | 79 | 2 | PF02187 | |
| Domain | GAS2 | 2.62e-04 | 6 | 79 | 2 | SM00243 | |
| Domain | Plectin_repeat | 3.66e-04 | 7 | 79 | 2 | IPR001101 | |
| Domain | Plectin | 3.66e-04 | 7 | 79 | 2 | PF00681 | |
| Domain | PLEC | 3.66e-04 | 7 | 79 | 2 | SM00250 | |
| Domain | Kinesin_motor_CS | 6.92e-04 | 41 | 79 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 7.96e-04 | 43 | 79 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 8.51e-04 | 44 | 79 | 3 | PS00411 | |
| Domain | - | 8.51e-04 | 44 | 79 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 8.51e-04 | 44 | 79 | 3 | IPR001752 | |
| Domain | Kinesin | 8.51e-04 | 44 | 79 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 8.51e-04 | 44 | 79 | 3 | PS50067 | |
| Domain | KISc | 8.51e-04 | 44 | 79 | 3 | SM00129 | |
| Domain | Znf_CXXC | 9.48e-04 | 11 | 79 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 9.48e-04 | 11 | 79 | 2 | PS51058 | |
| Domain | zf-CXXC | 9.48e-04 | 11 | 79 | 2 | PF02008 | |
| Domain | L27 | 1.34e-03 | 13 | 79 | 2 | SM00569 | |
| Domain | L27 | 1.34e-03 | 13 | 79 | 2 | PS51022 | |
| Domain | L27_dom | 1.34e-03 | 13 | 79 | 2 | IPR004172 | |
| Domain | Kinase-like_dom | 2.05e-03 | 542 | 79 | 8 | IPR011009 | |
| Domain | SH3 | 2.22e-03 | 216 | 79 | 5 | PS50002 | |
| Domain | SH3_domain | 2.41e-03 | 220 | 79 | 5 | IPR001452 | |
| Domain | CH | 2.63e-03 | 65 | 79 | 3 | SM00033 | |
| Domain | CH | 3.25e-03 | 70 | 79 | 3 | PF00307 | |
| Domain | - | 3.39e-03 | 71 | 79 | 3 | 1.10.418.10 | |
| Domain | CH | 3.66e-03 | 73 | 79 | 3 | PS50021 | |
| Domain | EF-hand_1 | 3.95e-03 | 152 | 79 | 4 | PF00036 | |
| Domain | CH-domain | 3.95e-03 | 75 | 79 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 4.22e-03 | 23 | 79 | 2 | IPR001589 | |
| Domain | Spectrin | 4.22e-03 | 23 | 79 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.22e-03 | 23 | 79 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.22e-03 | 23 | 79 | 2 | PS00019 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.75e-05 | 42 | 59 | 4 | M41828 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 3.02e-05 | 43 | 59 | 4 | MM15679 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 4.15e-05 | 153 | 59 | 6 | M39546 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION | 1.71e-04 | 5 | 59 | 2 | M45010 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.23e-04 | 132 | 59 | 5 | M11355 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 2.56e-04 | 6 | 59 | 2 | M47523 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 7.12e-04 | 42 | 59 | 3 | M41826 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 7.12e-04 | 42 | 59 | 3 | MM15677 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 7.63e-04 | 43 | 59 | 3 | M41827 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 8.16e-04 | 44 | 59 | 3 | MM15678 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FSIP2 MAGI1 SYNRG CCDC88A LATS1 DST CDC42BPA RAPH1 LMO7 TJP1 PPFIA1 MATR3 TET1 SEC16A ANKRD11 KIF14 ANKRD17 MACF1 CEP131 KIF2A R3HDM1 PATJ FAM83B SPICE1 NEDD4 | 9.83e-21 | 861 | 82 | 25 | 36931259 |
| Pubmed | MAGI1 LATS1 DST UBR5 LMO7 TJP1 PPFIA1 SEC16A KIF14 CEP131 KIF2A R3HDM1 PATJ FAM83B SPICE1 | 1.50e-13 | 446 | 82 | 15 | 24255178 | |
| Pubmed | KIF20A CCDC88A TENT4B DST CDC42BPA UBR5 TJP1 PPFIA1 SEC16A ZFHX3 CEP131 ANKRD50 SPEN CLEC16A FAM83B CASK | 3.50e-11 | 777 | 82 | 16 | 35844135 | |
| Pubmed | MAGI1 MAGI2 CCDC88A DST UBR5 TJP1 PPFIA1 MATR3 ZBTB22 SEC16A ANKRD17 MACF1 CEP131 KIF2A SPICE1 CASK NEDD4 | 8.62e-11 | 963 | 82 | 17 | 28671696 | |
| Pubmed | CCDC88A DST ZFHX4 RAPH1 UBR5 PPFIA1 TET1 SEC16A KIF14 ANKRD17 ZFHX3 CEP131 | 3.01e-10 | 418 | 82 | 12 | 34709266 | |
| Pubmed | SYNRG LATS1 RAPH1 LMO7 TJP1 MATR3 TET1 SEC16A KIF14 PATJ SPEN SNX9 SAP130 | 5.42e-10 | 549 | 82 | 13 | 38280479 | |
| Pubmed | MAGI1 CCDC88A LATS1 DST CDC42BPA PPFIA1 SEC16A ANKRD17 MACF1 ANKRD50 PATJ SNX9 FAM83B SPICE1 | 1.13e-09 | 708 | 82 | 14 | 39231216 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG CCDC88A UBR5 LMO7 SEC16A HIPK2 KIF14 MACF1 CEP131 PATJ SPEN SNX9 FAM83B | 1.24e-09 | 588 | 82 | 13 | 38580884 |
| Pubmed | SP3 GTF2H1 CEACAM5 TENT4B DST CDC42BPA PPFIA1 CXXC4 ANKRD11 KIF14 ANKRD17 MACF1 ZFHX3 CEP131 KIF2A PATJ SPEN FAM83B CASK | 1.47e-09 | 1497 | 82 | 19 | 31527615 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | BMI1 SP3 ZNF469 LATS1 IPCEF1 TSC22D2 PATJ SPEN SAP130 RIC1 NEDD4 | 5.79e-09 | 430 | 82 | 11 | 35044719 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.41e-08 | 361 | 82 | 10 | 26167880 | |
| Pubmed | 1.82e-08 | 274 | 82 | 9 | 34244482 | ||
| Pubmed | MAGI1 CCDC88A LATS1 DST CDC42BPA SIMC1 HIPK2 ANKRD17 MACF1 NCKAP5 PYGO1 | 2.03e-08 | 486 | 82 | 11 | 20936779 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CCDC88A DST CDC42BPA RAPH1 FMN1 PPFIA1 DDR2 ANKRD50 SNX9 CASK | 2.13e-08 | 377 | 82 | 10 | 38117590 |
| Pubmed | 3.62e-08 | 209 | 82 | 8 | 36779422 | ||
| Pubmed | FLG DST CDC42BPA ZFHX4 MATR3 EPC1 SEC16A HIPK2 ANKRD17 ELF1 ZFHX3 CEP131 R3HDM1 SPEN SAP130 PYGO1 | 1.96e-07 | 1429 | 82 | 16 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FBXO38 SEC16B SYNRG LATS1 RAPH1 LMO7 MATR3 SEC16A ANKRD17 ELF1 SPEN SPICE1 | 2.70e-07 | 774 | 82 | 12 | 15302935 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.81e-07 | 184 | 82 | 7 | 32908313 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 CDC42BPA TJP1 ANKRD11 HIPK2 ANKRD17 MACF1 ZFHX3 SEMA6A PATJ ZNF236 SNX9 SAP130 CLEC16A RIC1 CASK | 3.39e-07 | 1489 | 82 | 16 | 28611215 |
| Pubmed | 3.59e-07 | 282 | 82 | 8 | 23667531 | ||
| Pubmed | CCDC88A DST CDC42BPA LMO7 MATR3 TET1 ANKRD17 ANKRD50 CLOCK ZNF646 | 4.89e-07 | 529 | 82 | 10 | 14621295 | |
| Pubmed | 6.88e-07 | 421 | 82 | 9 | 36976175 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DST UBR5 LMO7 TJP1 MATR3 SEC16A KIF14 MACF1 CEP131 KIF2A SPEN SNX9 FAM83B | 7.89e-07 | 1024 | 82 | 13 | 24711643 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 8.87e-07 | 565 | 82 | 10 | 25468996 | |
| Pubmed | 1.42e-06 | 35 | 82 | 4 | 33864728 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 1.60e-06 | 36 | 82 | 4 | 26053890 | |
| Pubmed | KIF20A ZNF469 GTF2H1 ZFHX4 UBR5 PPFIA1 EPC1 SEC16A ANKRD17 MACF1 ZFHX3 SAP130 ZNF646 | 2.05e-06 | 1116 | 82 | 13 | 31753913 | |
| Pubmed | 2.06e-06 | 11 | 82 | 3 | 15843429 | ||
| Pubmed | 2.25e-06 | 251 | 82 | 7 | 29778605 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.56e-06 | 256 | 82 | 7 | 33397691 | |
| Pubmed | 3.06e-06 | 263 | 82 | 7 | 34702444 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG CCDC88A LATS1 RAPH1 UBR5 TJP1 SIMC1 KIF14 SNX9 CLEC16A FAM83B | 5.20e-06 | 853 | 82 | 11 | 28718761 |
| Pubmed | BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX. | 5.49e-06 | 2 | 82 | 2 | 29337063 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11002341 | ||
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 5.49e-06 | 2 | 82 | 2 | 23523645 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 5.49e-06 | 2 | 82 | 2 | 10873665 | |
| Pubmed | MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | 5.49e-06 | 2 | 82 | 2 | 22381734 | |
| Pubmed | 5.50e-06 | 407 | 82 | 8 | 12693553 | ||
| Pubmed | 5.63e-06 | 15 | 82 | 3 | 23782696 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 6.28e-06 | 552 | 82 | 9 | 10737800 | |
| Pubmed | FBXO38 CCDC88A CDC42BPA PTPRH RAPH1 TJP1 PPFIA1 SEC16A KIF14 CEP131 SPICE1 CASK | 6.33e-06 | 1049 | 82 | 12 | 27880917 | |
| Pubmed | MAGI1 LATS1 CDC42BPA RNF6 LMO7 TJP1 MATR3 SEC16A ANKRD17 KIF2A PATJ FAM83B SPICE1 | 6.82e-06 | 1247 | 82 | 13 | 27684187 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KIF20A SYNRG LMO7 TJP1 PPFIA1 ANKRD17 MACF1 R3HDM1 SPEN SNX9 | 7.97e-06 | 724 | 82 | 10 | 36232890 |
| Pubmed | FMN1 PPFIA1 MATR3 TET1 SEC16A HIPK2 ANKRD17 MACF1 KIF2A ANKRD50 PATJ TUB | 8.80e-06 | 1084 | 82 | 12 | 11544199 | |
| Pubmed | 1.27e-05 | 60 | 82 | 4 | 19075228 | ||
| Pubmed | 1.59e-05 | 225 | 82 | 6 | 12168954 | ||
| Pubmed | 1.61e-05 | 472 | 82 | 8 | 38943005 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 1.64e-05 | 3 | 82 | 2 | 12399109 | |
| Pubmed | Carom: a novel membrane-associated guanylate kinase-interacting protein with two SH3 domains. | 1.64e-05 | 3 | 82 | 2 | 14627983 | |
| Pubmed | MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2. | 1.64e-05 | 3 | 82 | 2 | 32730644 | |
| Pubmed | Characterization of human Sec16B: indications of specialized, non-redundant functions. | 1.64e-05 | 3 | 82 | 2 | 22355596 | |
| Pubmed | SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma. | 1.64e-05 | 3 | 82 | 2 | 32641685 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 36413827 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31425296 | ||
| Pubmed | 1.99e-05 | 234 | 82 | 6 | 36243803 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 2.00e-05 | 639 | 82 | 9 | 23443559 | |
| Pubmed | 2.16e-05 | 23 | 82 | 3 | 16637659 | ||
| Pubmed | 2.38e-05 | 653 | 82 | 9 | 22586326 | ||
| Pubmed | 2.80e-05 | 25 | 82 | 3 | 23873930 | ||
| Pubmed | 3.01e-05 | 151 | 82 | 5 | 17043677 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | KIF20A SYNRG CCDC88A RAPH1 UBR5 TJP1 SEC16A AGFG2 ANKRD50 R3HDM1 SPICE1 | 3.21e-05 | 1038 | 82 | 11 | 26673895 |
| Pubmed | Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. | 3.28e-05 | 4 | 82 | 2 | 10856295 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 23300874 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 8954775 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 17192411 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTF2H1 TENT4B DST LMO7 TJP1 MATR3 KIF14 ANKRD17 KIF2A PATJ SPEN FAM83B | 3.78e-05 | 1257 | 82 | 12 | 36526897 |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 23341029 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 16105026 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 28831123 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 28425671 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 21768384 | ||
| Pubmed | A bifurcated signaling cascade of NIMA-related kinases controls distinct kinesins in anaphase. | 5.47e-05 | 5 | 82 | 2 | 28630147 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.93e-05 | 934 | 82 | 10 | 33916271 | |
| Pubmed | 7.76e-05 | 95 | 82 | 4 | 29490077 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 20491914 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 15509766 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 17397395 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 15863617 | ||
| Pubmed | KIF14 and citron kinase act together to promote efficient cytokinesis. | 8.19e-05 | 6 | 82 | 2 | 16431929 | |
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 8.19e-05 | 6 | 82 | 2 | 9647693 | |
| Pubmed | 9.18e-05 | 191 | 82 | 5 | 33762435 | ||
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 9.26e-05 | 37 | 82 | 3 | 11416179 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 9.85e-05 | 101 | 82 | 4 | 24613305 | |
| Pubmed | 1.10e-04 | 104 | 82 | 4 | 9205841 | ||
| Pubmed | 1.17e-04 | 40 | 82 | 3 | 30865227 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.22e-04 | 203 | 82 | 5 | 22083510 | |
| Pubmed | FLG LATS1 DST RAPH1 LMO7 TJP1 PPFIA1 MATR3 MACF1 SPEN SNX9 CCDC158 | 1.39e-04 | 1442 | 82 | 12 | 35575683 | |
| Pubmed | 1.43e-04 | 645 | 82 | 8 | 25281560 | ||
| Pubmed | 1.51e-04 | 650 | 82 | 8 | 38777146 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 29155075 | ||
| Pubmed | The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. | 1.52e-04 | 8 | 82 | 2 | 14988405 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 22006950 | ||
| Pubmed | Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. | 1.52e-04 | 8 | 82 | 2 | 30022164 | |
| Pubmed | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. | 1.52e-04 | 8 | 82 | 2 | 16316992 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.78e-04 | 498 | 82 | 7 | 36634849 | |
| Pubmed | 1.80e-04 | 118 | 82 | 4 | 30979931 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.86e-04 | 351 | 82 | 6 | 38297188 | |
| Pubmed | 1.89e-04 | 503 | 82 | 7 | 16964243 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.92e-04 | 120 | 82 | 4 | 31413325 | |
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 1.96e-04 | 9 | 82 | 2 | 28169360 | |
| Interaction | YWHAG interactions | MAGI1 SYNRG CCDC88A LATS1 DST CDC42BPA RAPH1 LMO7 TJP1 PPFIA1 MATR3 SIMC1 TET1 SEC16A ANKRD11 KIF14 ANKRD17 MACF1 CEP131 KIF2A R3HDM1 PATJ FAM83B SPICE1 NEDD4 | 9.06e-12 | 1248 | 81 | 25 | int:YWHAG |
| Interaction | SFN interactions | MAGI1 BMI1 SYNRG CCDC88A LATS1 DST CDC42BPA LMO7 TJP1 PPFIA1 MATR3 KIF14 ANKRD17 MACF1 CEP131 KIF2A TNS4 SAP130 FAM83B | 2.44e-11 | 692 | 81 | 19 | int:SFN |
| Interaction | YWHAH interactions | MAGI1 SYNRG CCDC88A LATS1 DST CDC42BPA LMO7 TJP1 PPFIA1 MATR3 TET1 SEC16A ANKRD11 KIF14 ANKRD17 MACF1 CEP131 KIF2A R3HDM1 PATJ CLEC16A FAM83B NEDD4 | 3.38e-11 | 1102 | 81 | 23 | int:YWHAH |
| Interaction | RCOR1 interactions | CCDC88A DST ZFHX4 RAPH1 UBR5 PPFIA1 MATR3 TET1 SEC16A ANKRD17 ZFHX3 CEP131 SPEN CLOCK | 9.56e-09 | 494 | 81 | 14 | int:RCOR1 |
| Interaction | OCLN interactions | MAGI1 CCDC88A DST CDC42BPA TJP1 PPFIA1 LAMP3 KIF14 MACF1 PATJ SNX9 FAM83B CASK NEDD4 | 1.11e-08 | 500 | 81 | 14 | int:OCLN |
| Interaction | PHF21A interactions | SP3 CCDC88A DST ZFHX4 UBR5 PPFIA1 TET1 SEC16A KIF14 ZFHX3 CEP131 CLOCK | 1.20e-08 | 343 | 81 | 12 | int:PHF21A |
| Interaction | YWHAB interactions | MAGI1 SYNRG CCDC88A LATS1 DST CDC42BPA LMO7 TJP1 PPFIA1 MATR3 KIF14 ANKRD17 MACF1 CEP131 KIF2A R3HDM1 SAP130 FAM83B NEDD4 | 1.42e-08 | 1014 | 81 | 19 | int:YWHAB |
| Interaction | LATS1 interactions | MAGI1 CCDC88A LATS1 MYOM1 TJP1 MATR3 SEC16A KIF14 CEP131 R3HDM1 PATJ SPICE1 NEDD4 | 2.09e-08 | 440 | 81 | 13 | int:LATS1 |
| Interaction | MAPRE3 interactions | CCDC88A DST LMO7 KIF14 MACF1 NCKAP5 CEP131 KIF2A FAM83B SPICE1 | 2.85e-08 | 230 | 81 | 10 | int:MAPRE3 |
| Interaction | PARD3 interactions | KIF20A MAGI1 CCDC88A LATS1 DST CDC42BPA LMO7 TJP1 KIF14 PATJ CCDC85A | 2.97e-08 | 298 | 81 | 11 | int:PARD3 |
| Interaction | C11orf52 interactions | MAGI1 CCDC88A DST CDC42BPA PPFIA1 MACF1 SEMA6A ANKRD50 SNX9 FAM83B CASK | 4.60e-08 | 311 | 81 | 11 | int:C11orf52 |
| Interaction | HDAC1 interactions | KIF20A SP3 DST CDC42BPA ZFHX4 RAPH1 UBR5 LMO7 PPFIA1 MATR3 TET1 KIF14 ANKRD17 ZFHX3 CEP131 KIF2A SPEN SNX9 SAP130 | 5.81e-08 | 1108 | 81 | 19 | int:HDAC1 |
| Interaction | EPB41L4A interactions | 9.31e-08 | 140 | 81 | 8 | int:EPB41L4A | |
| Interaction | CAV1 interactions | KIF20A MAGI1 CCDC88A LATS1 DST CDC42BPA PPFIA1 LAMP3 KIF14 MACF1 SEMA6A RIC1 FAM83B CASK NEDD4 | 1.67e-07 | 724 | 81 | 15 | int:CAV1 |
| Interaction | YWHAZ interactions | FSIP2 SYNRG CCDC88A LATS1 DST CDC42BPA RAPH1 LMO7 TJP1 PPFIA1 MATR3 SIMC1 KIF14 ANKRD17 MACF1 CEP131 KIF2A R3HDM1 FAM83B NEDD4 | 1.81e-07 | 1319 | 81 | 20 | int:YWHAZ |
| Interaction | LATS2 interactions | MAGI1 LATS1 UBR5 TJP1 PPFIA1 SEC16A CEP131 PATJ SPICE1 NEDD4 | 2.41e-07 | 289 | 81 | 10 | int:LATS2 |
| Interaction | CXADR interactions | MAGI1 CCDC88A DST CDC42BPA TJP1 PPFIA1 LAMP3 KIF14 MACF1 SNX9 FAM83B | 2.58e-07 | 369 | 81 | 11 | int:CXADR |
| Interaction | YWHAE interactions | BMI1 SYNRG CCDC88A LATS1 DST CDC42BPA LMO7 PPFIA1 MATR3 TET1 KIF14 ANKRD17 MACF1 CEP131 R3HDM1 SAP130 FAM83B CASK NEDD4 | 4.07e-07 | 1256 | 81 | 19 | int:YWHAE |
| Interaction | FLOT1 interactions | KIF20A MAGI1 CCDC88A DST CDC42BPA TJP1 PPFIA1 KIF14 MACF1 PATJ FAM83B CASK | 4.15e-07 | 475 | 81 | 12 | int:FLOT1 |
| Interaction | AMOT interactions | MAGI1 LATS1 TJP1 PPFIA1 SEC16A KIF14 CEP131 PATJ SPICE1 NEDD4 | 4.87e-07 | 312 | 81 | 10 | int:AMOT |
| Interaction | AFDN interactions | MAGI1 CCDC88A DST CDC42BPA TJP1 KIF14 MACF1 CEP131 PATJ FAM83B | 8.81e-07 | 333 | 81 | 10 | int:AFDN |
| Interaction | CEP135 interactions | 1.45e-06 | 272 | 81 | 9 | int:CEP135 | |
| Interaction | FMR1 interactions | KIF20A MAGI1 TJP1 MATR3 KIF14 ANKRD17 MACF1 KIF2A R3HDM1 SPICE1 CASK NEDD4 | 1.48e-06 | 536 | 81 | 12 | int:FMR1 |
| Interaction | CNTNAP4 interactions | 1.68e-06 | 22 | 81 | 4 | int:CNTNAP4 | |
| Interaction | KCNA3 interactions | MAGI1 CCDC88A LATS1 DST CDC42BPA PPFIA1 SEC16A ANKRD17 MACF1 ANKRD50 PATJ SPEN SNX9 FAM83B SPICE1 | 1.72e-06 | 871 | 81 | 15 | int:KCNA3 |
| Interaction | YWHAQ interactions | SYNRG CCDC88A LATS1 DST CDC42BPA LMO7 TJP1 PPFIA1 MATR3 TET1 KIF14 ANKRD17 MACF1 CEP131 R3HDM1 FAM83B NEDD4 | 1.74e-06 | 1118 | 81 | 17 | int:YWHAQ |
| Interaction | SAV1 interactions | 2.52e-06 | 151 | 81 | 7 | int:SAV1 | |
| Interaction | MCAM interactions | CCDC88A DST CDC42BPA RAPH1 FMN1 PPFIA1 DDR2 LAMP3 ANKRD50 SNX9 CASK | 2.64e-06 | 468 | 81 | 11 | int:MCAM |
| Interaction | EBAG9 interactions | 3.52e-06 | 303 | 81 | 9 | int:EBAG9 | |
| Interaction | PPP1R12C interactions | 3.59e-06 | 58 | 81 | 5 | int:PPP1R12C | |
| Interaction | FHL2 interactions | 4.16e-06 | 396 | 81 | 10 | int:FHL2 | |
| Interaction | KDM1A interactions | BMI1 CCDC88A DST ZFHX4 RAPH1 UBR5 PPFIA1 TET1 SEC16A KIF14 ANKRD17 ZFHX3 CEP131 CLOCK SPICE1 | 4.43e-06 | 941 | 81 | 15 | int:KDM1A |
| Interaction | GLDC interactions | 5.63e-06 | 321 | 81 | 9 | int:GLDC | |
| Interaction | LZTS2 interactions | GTF2H1 CCDC88A LATS1 TJP1 SEC16A ANKRD11 HIPK2 KIF14 CEP131 CLEC16A FAM83B | 6.22e-06 | 512 | 81 | 11 | int:LZTS2 |
| Interaction | TRIM37 interactions | KIF20A BMI1 RNF6 UBR5 TJP1 SEC16A ANKRD11 KIF14 NCKAP5 CEP131 SPEN SPICE1 | 7.74e-06 | 630 | 81 | 12 | int:TRIM37 |
| Interaction | AR interactions | BMI1 GTF2H1 CDC42BPA RNF6 UBR5 TJP1 MATR3 EPC1 SEC16A HIPK2 ZFHX3 CEP131 TNS4 SAP130 WAC | 8.36e-06 | 992 | 81 | 15 | int:AR |
| Interaction | RBM6 interactions | 8.45e-06 | 119 | 81 | 6 | int:RBM6 | |
| Interaction | C4BPA interactions | 9.07e-06 | 33 | 81 | 4 | int:C4BPA | |
| Interaction | PABPC1L2A interactions | 1.01e-05 | 11 | 81 | 3 | int:PABPC1L2A | |
| Interaction | RABGAP1L interactions | 1.02e-05 | 123 | 81 | 6 | int:RABGAP1L | |
| Interaction | CTNNA1 interactions | 1.05e-05 | 347 | 81 | 9 | int:CTNNA1 | |
| Interaction | SYNE3 interactions | SYNRG LATS1 DST LMO7 SEC16A KIF14 MACF1 CEP131 FAM83B SPICE1 | 1.13e-05 | 444 | 81 | 10 | int:SYNE3 |
| Interaction | STX6 interactions | SYNRG CCDC88A DST CDC42BPA PPFIA1 SEC16A LAMP3 MACF1 RIC1 FAM83B | 1.22e-05 | 448 | 81 | 10 | int:STX6 |
| Interaction | EZR interactions | BMI1 DST CDC42BPA RAPH1 LMO7 TJP1 SEC16A KIF14 MACF1 CASK NEDD4 | 1.28e-05 | 553 | 81 | 11 | int:EZR |
| Interaction | NRXN2 interactions | 1.34e-05 | 12 | 81 | 3 | int:NRXN2 | |
| Interaction | MTM1 interactions | 1.55e-05 | 78 | 81 | 5 | int:MTM1 | |
| Interaction | RAB35 interactions | BMI1 CCDC88A LATS1 DST CDC42BPA PPFIA1 KIF14 MACF1 FAM83B SPICE1 CASK | 1.78e-05 | 573 | 81 | 11 | int:RAB35 |
| Interaction | AP2B1 interactions | 1.87e-05 | 373 | 81 | 9 | int:AP2B1 | |
| Interaction | PUM1 interactions | 2.01e-05 | 287 | 81 | 8 | int:PUM1 | |
| Interaction | TJP2 interactions | 2.06e-05 | 288 | 81 | 8 | int:TJP2 | |
| Interaction | GJA1 interactions | CCDC88A DST CDC42BPA TJP1 PPFIA1 SEC16A LAMP3 MACF1 FAM83B CASK NEDD4 | 2.09e-05 | 583 | 81 | 11 | int:GJA1 |
| Interaction | TNIK interactions | 2.21e-05 | 381 | 81 | 9 | int:TNIK | |
| Interaction | VASP interactions | 2.39e-05 | 294 | 81 | 8 | int:VASP | |
| Interaction | GTSE1 interactions | 2.54e-05 | 215 | 81 | 7 | int:GTSE1 | |
| Interaction | APC interactions | 2.60e-05 | 389 | 81 | 9 | int:APC | |
| Interaction | UBAP2L interactions | 2.63e-05 | 298 | 81 | 8 | int:UBAP2L | |
| Interaction | PPHLN1 interactions | 2.71e-05 | 146 | 81 | 6 | int:PPHLN1 | |
| Interaction | TJP3 interactions | 2.75e-05 | 15 | 81 | 3 | int:TJP3 | |
| Interaction | RHOB interactions | KIF20A MAGI1 CCDC88A CDC42BPA RAPH1 TJP1 PPFIA1 DDR2 KIF14 MACF1 PATJ FAM83B CASK | 2.84e-05 | 840 | 81 | 13 | int:RHOB |
| Interaction | LYN interactions | KIF20A CCDC88A DST CDC42BPA PPFIA1 LAMP3 KIF14 MACF1 ANKRD50 SNX9 FAM83B CASK | 2.91e-05 | 720 | 81 | 12 | int:LYN |
| Interaction | SPTAN1 interactions | 2.93e-05 | 496 | 81 | 10 | int:SPTAN1 | |
| Interaction | DCTN1 interactions | KIF20A CCDC88A DST MATR3 SEC16A KIF14 MACF1 CEP131 KIF2A SPICE1 | 2.98e-05 | 497 | 81 | 10 | int:DCTN1 |
| Interaction | PKP2 interactions | 3.40e-05 | 225 | 81 | 7 | int:PKP2 | |
| Interaction | PFN1 interactions | 3.64e-05 | 509 | 81 | 10 | int:PFN1 | |
| Interaction | PPP1CC interactions | KIF20A SP3 LATS1 RAPH1 UBR5 LMO7 LAMP3 KIF14 CLOCK CLEC16A FAM83B CASK | 3.71e-05 | 738 | 81 | 12 | int:PPP1CC |
| Interaction | MAPRE1 interactions | 3.96e-05 | 514 | 81 | 10 | int:MAPRE1 | |
| Interaction | STK4 interactions | 4.37e-05 | 159 | 81 | 6 | int:STK4 | |
| Interaction | ANKRD28 interactions | 4.48e-05 | 235 | 81 | 7 | int:ANKRD28 | |
| Interaction | CTNNB1 interactions | KIF20A MAGI1 MAGI2 CCDC88A DST RNF6 UBR5 LMO7 TJP1 MATR3 DDR2 SEC16A KIF14 PYGO1 | 4.49e-05 | 1009 | 81 | 14 | int:CTNNB1 |
| Interaction | SYTL5 interactions | 4.89e-05 | 18 | 81 | 3 | int:SYTL5 | |
| Interaction | DPRX interactions | 4.89e-05 | 18 | 81 | 3 | int:DPRX | |
| Interaction | WWTR1 interactions | 4.89e-05 | 422 | 81 | 9 | int:WWTR1 | |
| Interaction | AURKB interactions | KIF20A BMI1 LATS1 UBR5 PPFIA1 MATR3 SEC16A KIF14 ANKRD17 MACF1 CEP131 CLEC16A | 4.99e-05 | 761 | 81 | 12 | int:AURKB |
| Interaction | SEC24B interactions | 5.12e-05 | 240 | 81 | 7 | int:SEC24B | |
| Interaction | ZYX interactions | 5.29e-05 | 329 | 81 | 8 | int:ZYX | |
| Interaction | TFIP11 interactions | 5.36e-05 | 427 | 81 | 9 | int:TFIP11 | |
| Interaction | PHLPP1 interactions | 5.76e-05 | 333 | 81 | 8 | int:PHLPP1 | |
| Interaction | CAMSAP2 interactions | 6.14e-05 | 169 | 81 | 6 | int:CAMSAP2 | |
| Interaction | PNMA2 interactions | 6.79e-05 | 251 | 81 | 7 | int:PNMA2 | |
| Interaction | ACTN1 interactions | 6.80e-05 | 341 | 81 | 8 | int:ACTN1 | |
| Interaction | LMO7 interactions | 7.93e-05 | 177 | 81 | 6 | int:LMO7 | |
| Interaction | PTEN interactions | FSIP2 MAGI2 BMI1 CCDC88A LATS1 CDC42BPA TJP1 MATR3 ANKRD11 KIF14 CEP131 SNX9 NEDD4 | 7.98e-05 | 929 | 81 | 13 | int:PTEN |
| Interaction | CDC14A interactions | 8.50e-05 | 111 | 81 | 5 | int:CDC14A | |
| Interaction | OTUD7A interactions | 8.71e-05 | 58 | 81 | 4 | int:OTUD7A | |
| Interaction | MYCBP2 interactions | 9.00e-05 | 355 | 81 | 8 | int:MYCBP2 | |
| Interaction | RAB1C interactions | 9.12e-05 | 22 | 81 | 3 | int:RAB1C | |
| Interaction | TBR1 interactions | 9.25e-05 | 113 | 81 | 5 | int:TBR1 | |
| Interaction | PRRC2B interactions | 9.53e-05 | 265 | 81 | 7 | int:PRRC2B | |
| Interaction | GSK3A interactions | 1.01e-04 | 464 | 81 | 9 | int:GSK3A | |
| Interaction | SEC31B interactions | 1.05e-04 | 23 | 81 | 3 | int:SEC31B | |
| Interaction | PPP1CB interactions | 1.10e-04 | 469 | 81 | 9 | int:PPP1CB | |
| Interaction | PAXBP1 interactions | 1.28e-04 | 121 | 81 | 5 | int:PAXBP1 | |
| Interaction | TLE3 interactions | 1.34e-04 | 376 | 81 | 8 | int:TLE3 | |
| Interaction | TNRC6B interactions | 1.40e-04 | 282 | 81 | 7 | int:TNRC6B | |
| Interaction | SLAIN2 interactions | 1.49e-04 | 125 | 81 | 5 | int:SLAIN2 | |
| Interaction | VPS33B interactions | 1.51e-04 | 199 | 81 | 6 | int:VPS33B | |
| Interaction | CLDN1 interactions | 1.52e-04 | 26 | 81 | 3 | int:CLDN1 | |
| Interaction | GPRC5A interactions | 1.62e-04 | 68 | 81 | 4 | int:GPRC5A | |
| Interaction | PRRC2A interactions | 1.69e-04 | 389 | 81 | 8 | int:PRRC2A | |
| Interaction | PLD1 interactions | 1.79e-04 | 130 | 81 | 5 | int:PLD1 | |
| Cytoband | 16p13.13 | 5.86e-04 | 20 | 82 | 2 | 16p13.13 | |
| Cytoband | 5q31.2 | 1.16e-03 | 28 | 82 | 2 | 5q31.2 | |
| Cytoband | 2p16.1 | 1.51e-03 | 32 | 82 | 2 | 2p16.1 | |
| Cytoband | 6p12.1 | 1.61e-03 | 33 | 82 | 2 | 6p12.1 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 9.38e-07 | 26 | 53 | 4 | 904 | |
| GeneFamily | PDZ domain containing | 5.30e-06 | 152 | 53 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.33e-04 | 8 | 53 | 2 | 939 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.30e-04 | 46 | 53 | 3 | 622 | |
| GeneFamily | Zinc fingers CXXC-type | 5.46e-04 | 12 | 53 | 2 | 136 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.64e-04 | 15 | 53 | 2 | 529 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.42e-03 | 25 | 53 | 2 | 775 | |
| GeneFamily | EF-hand domain containing | 3.86e-03 | 219 | 53 | 4 | 863 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 DST CDC42BPA UBR5 PPFIA1 DDR2 KIF14 ANKRD17 MACF1 ZFHX3 KIF2A TSC22D2 R3HDM1 SPEN CLOCK CLEC16A CASK NEDD4 | 1.23e-10 | 856 | 82 | 18 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DST CDC42BPA UBR5 PPFIA1 KIF14 ANKRD17 KIF2A R3HDM1 SPEN CLOCK CLEC16A CASK NEDD4 | 2.20e-09 | 466 | 82 | 13 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.41e-06 | 177 | 82 | 7 | M39245 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.59e-06 | 300 | 82 | 8 | M8702 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 6.74e-06 | 84 | 82 | 5 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 7.56e-06 | 86 | 82 | 5 | MM825 | |
| Coexpression | MILI_PSEUDOPODIA | 1.56e-05 | 48 | 82 | 4 | M17507 | |
| Coexpression | MILI_PSEUDOPODIA | 1.99e-05 | 51 | 82 | 4 | MM824 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 3.24e-05 | 116 | 82 | 5 | M2379 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 3.37e-05 | 117 | 82 | 5 | MM931 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 3.77e-05 | 523 | 82 | 9 | M12707 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP | 3.96e-05 | 200 | 82 | 6 | M8495 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 4.43e-05 | 534 | 82 | 9 | MM1054 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 1.29e-04 | 82 | 82 | 4 | M16458 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.42e-04 | 84 | 82 | 4 | M13008 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 1.49e-04 | 85 | 82 | 4 | MM1106 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 1.53e-04 | 161 | 82 | 5 | M11857 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 1.77e-04 | 166 | 82 | 5 | M344 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SYNRG SP3 CCDC88A LATS1 UBR5 IPCEF1 MATR3 EPC1 ANKRD11 MACF1 ELF1 KIF2A SPEN WAC | 2.03e-04 | 1492 | 82 | 14 | M40023 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | MAGI2 BMI1 FBXO38 SP3 CCDC88A ZFHX4 LMO7 DDR2 ZFHX3 NCKAP5 RIC1 PYGO1 | 2.56e-07 | 478 | 81 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | MAGI2 BMI1 SP3 CCDC88A LATS1 DST ZFHX4 LMO7 DDR2 ZFHX3 NCKAP5 RIC1 PYGO1 | 1.57e-05 | 836 | 81 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.75e-05 | 492 | 81 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | MAGI2 BMI1 FBXO38 SP3 CCDC88A DST ZFHX4 LMO7 DDR2 ZFHX3 NCKAP5 RIC1 PYGO1 | 1.87e-05 | 850 | 81 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 3.72e-05 | 429 | 81 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 4.43e-05 | 247 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | 4.61e-05 | 169 | 81 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 4.66e-05 | 249 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.39e-05 | 469 | 81 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MAGI1 CCDC88A LATS1 PPFIA1 TET1 EPC1 HIPK2 MACF1 R3HDM1 CLEC16A WAC | 1.78e-04 | 780 | 81 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_500 | 2.12e-04 | 142 | 81 | 5 | gudmap_developingKidney_e13.5_podocyte cells_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 2.27e-04 | 428 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-09 | 192 | 82 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.91e-08 | 170 | 82 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.41e-08 | 174 | 82 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.01e-08 | 184 | 82 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 5.01e-08 | 184 | 82 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.01e-08 | 184 | 82 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.20e-08 | 185 | 82 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 5.59e-08 | 187 | 82 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 6.02e-08 | 189 | 82 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.24e-08 | 190 | 82 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.24e-08 | 190 | 82 | 7 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.19e-08 | 194 | 82 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.27e-08 | 198 | 82 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.85e-08 | 200 | 82 | 7 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.31e-07 | 177 | 82 | 6 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-06 | 181 | 82 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 184 | 82 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.20e-06 | 185 | 82 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.24e-06 | 186 | 82 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 186 | 82 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-06 | 187 | 82 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.41e-06 | 190 | 82 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 194 | 82 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 194 | 82 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.63e-06 | 195 | 82 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.73e-06 | 197 | 82 | 6 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-06 | 198 | 82 | 6 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 131 | 82 | 5 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.12e-06 | 152 | 82 | 5 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 1.40e-05 | 166 | 82 | 5 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 1.40e-05 | 166 | 82 | 5 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.48e-05 | 168 | 82 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 169 | 82 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 173 | 82 | 5 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 173 | 82 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.85e-05 | 176 | 82 | 5 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 176 | 82 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.01e-05 | 179 | 82 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-05 | 179 | 82 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-05 | 180 | 82 | 5 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-05 | 180 | 82 | 5 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 181 | 82 | 5 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 181 | 82 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.17e-05 | 182 | 82 | 5 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 182 | 82 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 182 | 82 | 5 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 182 | 82 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-05 | 183 | 82 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 184 | 82 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 185 | 82 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 186 | 82 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.41e-05 | 186 | 82 | 5 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.48e-05 | 187 | 82 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.48e-05 | 187 | 82 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 189 | 82 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 190 | 82 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 191 | 82 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.74e-05 | 191 | 82 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 2.74e-05 | 191 | 82 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 191 | 82 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 191 | 82 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.81e-05 | 192 | 82 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-05 | 192 | 82 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 2.88e-05 | 193 | 82 | 5 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.88e-05 | 193 | 82 | 5 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 193 | 82 | 5 | c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-05 | 194 | 82 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 194 | 82 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 194 | 82 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 194 | 82 | 5 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 195 | 82 | 5 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-05 | 195 | 82 | 5 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 195 | 82 | 5 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-05 | 195 | 82 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 196 | 82 | 5 | 9e737eaa98fd49972fce64d1d4a4d1f34b9bcb96 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 196 | 82 | 5 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 196 | 82 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | droplet-Lung-30m-Endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 196 | 82 | 5 | 58871891185aa7e1e4ab9b99cd25c1ca3c932cc8 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 196 | 82 | 5 | 99a7f2e57774884216525897dcd32a289107548b | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.10e-05 | 196 | 82 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 196 | 82 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 197 | 82 | 5 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 82 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-05 | 197 | 82 | 5 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 98 | 82 | 4 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.25e-05 | 198 | 82 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.25e-05 | 198 | 82 | 5 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.15e-05 | 50 | 50 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of MAP4K4 | 1.36e-04 | 172 | 50 | 6 | GCM_MAP4K4 | |
| Computational | Neighborhood of PSMC2 | 1.85e-04 | 115 | 50 | 5 | MORF_PSMC2 | |
| Drug | mycophenolic acid and ribavirin | 8.61e-07 | 6 | 81 | 3 | CID006478984 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.39e-06 | 178 | 81 | 7 | 3998_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | 7.06e-06 | 199 | 81 | 7 | 3073_UP | |
| Disease | Microcephaly | 3.37e-05 | 67 | 80 | 4 | C0025958 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 6.02e-05 | 364 | 80 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | cortical surface area measurement | MAGI1 ZNF469 CCDC88A RAPH1 TJP1 PPFIA1 HIPK2 MACF1 ZFHX3 NCKAP5 SEMA6A TSC22D2 AGBL5 | 6.33e-05 | 1345 | 80 | 13 | EFO_0010736 |
| Disease | Large cell carcinoma of lung | 8.99e-05 | 32 | 80 | 3 | C0345958 | |
| Disease | obesity (implicated_via_orthology) | 3.02e-04 | 215 | 80 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | body fat percentage | 3.64e-04 | 488 | 80 | 7 | EFO_0007800 | |
| Disease | PR interval | 3.96e-04 | 495 | 80 | 7 | EFO_0004462 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 4.71e-04 | 12 | 80 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | retinal vasculature measurement | 5.13e-04 | 517 | 80 | 7 | EFO_0010554 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 5.55e-04 | 13 | 80 | 2 | OBA_2045174 | |
| Disease | photoreceptor cell layer thickness measurement | 7.15e-04 | 148 | 80 | 4 | EFO_0803370 | |
| Disease | brain measurement, neuroimaging measurement | 7.39e-04 | 550 | 80 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 9.61e-04 | 17 | 80 | 2 | C1839839 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.37e-03 | 447 | 80 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | open-angle glaucoma | 1.83e-03 | 191 | 80 | 4 | EFO_0004190 | |
| Disease | alcohol consumption measurement | MAGI1 MAGI2 RAPH1 DDR2 CXXC4 ANKRD11 ZFHX3 NCKAP5 KIF2A CLEC16A | 1.91e-03 | 1242 | 80 | 10 | EFO_0007878 |
| Disease | nighttime rest measurement | 1.93e-03 | 24 | 80 | 2 | EFO_0007827 | |
| Disease | Neurodevelopmental Disorders | 2.09e-03 | 93 | 80 | 3 | C1535926 | |
| Disease | atopic asthma | 2.13e-03 | 199 | 80 | 4 | EFO_0010638 | |
| Disease | chronotype measurement | 2.69e-03 | 882 | 80 | 8 | EFO_0008328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLNSQSSSEHQPSSC | 341 | Q8NDL9 | |
| QPSNITQTSSSHSAL | 721 | Q9H2F5 | |
| SDPSLSSSATSNRNQ | 311 | P32519 | |
| SSTSSHGSSAAQKQN | 521 | Q6UB99 | |
| TCQANNSASGHSRTT | 476 | P06731 | |
| SSTTQSLGQSHNSPS | 1236 | Q9ULJ7 | |
| ASSQADSSRHSQVGQ | 591 | P20930 | |
| SSNSNSSRKSDNHSP | 1626 | O75179 | |
| ASGRSTNSHQSSTEN | 336 | Q15032 | |
| SSIPESQSNHSNQSD | 541 | Q70E73 | |
| EASQTQNPRSSSTHS | 436 | Q4ADV7 | |
| NSASQSSTHKQTSPV | 506 | Q68DA7 | |
| TSNSTNKSQHGSARL | 506 | Q8NDF8 | |
| SRQSPANGHSSTNNS | 586 | O14936 | |
| SQNSSSLNALTHSSR | 21 | Q15058 | |
| NQLTTVHNQAPSSTS | 586 | Q9H2X6 | |
| SSSLNQQGAHSALSS | 61 | P43243 | |
| SQNSSQHSVSSHRSL | 741 | Q96QZ7 | |
| ATYTNSNHAAPSSNA | 891 | Q86UL8 | |
| AVSQPASSSNHSSRR | 731 | P46934 | |
| ASSSNHSSRRGSLQA | 736 | P46934 | |
| NRASHSANSQPSATT | 471 | O95835 | |
| NNRSSSPSEQGSNST | 456 | Q16832 | |
| SPNRSTSVSSQAAQA | 7416 | Q03001 | |
| TSNSPSGNHQSSFAN | 296 | P35226 | |
| CNTNISRSSSPAHQD | 6891 | Q5CZC0 | |
| GRTSTSNSNNNASLH | 1591 | Q3V6T2 | |
| SSPRRKHSSSSNSQG | 826 | Q5T0W9 | |
| ASPTRSSSSASQSNH | 3356 | O94854 | |
| SHSPSASQSGSQLRN | 1591 | Q8WWI1 | |
| VSNPSSSNSSQDSLH | 781 | Q13136 | |
| TVSHTTGNTTQPSNQ | 151 | Q9UQV4 | |
| SGLHASSPTASQNNS | 396 | Q9UKI9 | |
| PTRSSSSASQSNHSC | 7231 | Q9UPN3 | |
| NHPASNTTSTKNNNS | 6 | Q99463 | |
| TVGNSSSHNTASQSP | 711 | Q6PIJ6 | |
| RTSGQTSANAHSSRS | 421 | O00139 | |
| HASQTQSLTAQQASS | 171 | Q8WWN9 | |
| ANLADCPQNHSSSSS | 106 | Q9H2H0 | |
| RSQSASDAPLSQQHT | 421 | Q6QEF8 | |
| NSAASFSGHATPSQQ | 501 | Q96PX6 | |
| RSHSNVPSSQSTASF | 871 | Q5M9N0 | |
| NPASSQLSRSQHSAS | 246 | D6RIA3 | |
| VNRNSSHNSRSSSSS | 401 | Q8N7B9 | |
| KNVSSATHSARNNTG | 231 | Q9UPN4 | |
| NSSSNNLTRNSEHEP | 251 | Q9H756 | |
| NSRSSSTEATNNNPA | 286 | Q9Y3Y4 | |
| STAQASSSAASNNHQ | 86 | Q9Y5X1 | |
| THTQLHSNSQPQSRT | 11 | Q05952 | |
| HRGSRSQSSSQSPAS | 41 | Q05952 | |
| SQSSSQSPASHRNPT | 46 | Q05952 | |
| AQSQQLSSHTPVSRS | 536 | O75157 | |
| PASSKTSNSQHGNSA | 481 | Q9UMZ2 | |
| PTHNISCQSNSRSSA | 776 | O14513 | |
| PRANASRTNFSSHTN | 246 | Q9Y252 | |
| NNSRSSSSSSNQKAP | 171 | Q8NDZ2 | |
| ALHSSNSHSSNPSNN | 106 | Q9BTA9 | |
| SDSPRHSTASNSSNL | 1691 | Q5VT25 | |
| SHSNTQQSRSPTFSE | 631 | Q8N0Z3 | |
| TLSNSHINSATNQAS | 976 | Q8NFU7 | |
| STSSQPVSQSHARTS | 191 | O95081 | |
| SGHSQQTSLPSQTQS | 641 | O15516 | |
| QCINQHSSPSLSSQS | 886 | Q2KHT3 | |
| RLNVNATDSSSTSNH | 146 | P32780 | |
| SQSAASSNNTYPHLS | 3456 | Q86UP3 | |
| GSANQRTHSTSSPQV | 186 | Q8TAG5 | |
| HSSQSRNQSPQRLAS | 246 | Q96T58 | |
| SLASQQSVASHPRQS | 1016 | O15027 | |
| RQGENSTHQQSASAS | 1041 | Q9UBZ9 | |
| SNSSHQSSSRSLESP | 296 | Q8IZW8 | |
| TNGNVHRPSNNSTVS | 91 | Q8NI35 | |
| QSFASTHLNQNSSRS | 366 | O95235 | |
| QNTNSLTTSSGQVHS | 351 | Q02447 | |
| RNNTNSSNSSHLSRN | 936 | Q9H2E6 | |
| SSNSSHLSRNQSFGR | 941 | Q9H2E6 | |
| HSQSASTNAPAQGSS | 651 | Q9H0E3 | |
| NSSQLQPGSHSSCSQ | 1521 | O15015 | |
| TNSETHFQSNSRNPC | 171 | Q96JE7 | |
| TASDFQSDSPQSHRN | 2386 | Q96JG9 | |
| QSDSPQSHRNASHQT | 2391 | Q96JG9 | |
| TNPASSTSAVNHNVN | 936 | Q07157 | |
| QATSASSQPSSQAVS | 341 | Q9UL36 | |
| NSSRETRNATTAHNP | 196 | Q9HD43 | |
| NSSSSSQLNSNTRPS | 206 | P50607 | |
| SHASSRASENQSPSS | 191 | O15209 | |
| TQHQRAASTAPSSTS | 1721 | O95071 | |
| PSTASTSQSAAHSND | 3581 | Q15911 | |
| ASSSQQQASQHALSS | 66 | P52179 |